Danilo Fliser
#138,409
Most Influential Person Now
Danilo Fliser's AcademicInfluence.com Rankings
Danilo Fliserphilosophy Degrees
Philosophy
#7105
World Rank
#10266
Historical Rank
Logic
#4181
World Rank
#5441
Historical Rank
Danilo Fliserbiology Degrees
Biology
#9634
World Rank
#12859
Historical Rank
Biochemistry
#1484
World Rank
#1611
Historical Rank
Download Badge
Philosophy Biology
Danilo Fliser's Degrees
- Doctorate Medicine Stanford University
Why Is Danilo Fliser Influential?
(Suggest an Edit or Addition)Danilo Fliser's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. (2007) (696)
- Erythropoietin regulates endothelial progenitor cells. (2004) (526)
- SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. (2011) (489)
- A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathy† (2012) (474)
- CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. (2012) (463)
- Simvastatin Versus Ezetimibe: Pleiotropic and Lipid-Lowering Effects on Endothelial Function in Humans (2005) (458)
- Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease* (2010) (425)
- Antiinflammatory Effects of Angiotensin II Subtype 1 Receptor Blockade in Hypertensive Patients With Microinflammation (2004) (419)
- Serum cystatin C concentration as a marker of renal dysfunction in the elderly. (2001) (416)
- Cardiovascular Effects of Systemic Nitric Oxide Synthase Inhibition With Asymmetrical Dimethylarginine in Humans (2004) (399)
- Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. (2002) (376)
- Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study. (2005) (344)
- Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. (1998) (335)
- Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. (2005) (332)
- Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis. (2006) (331)
- Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure (2014) (328)
- Oxidant Stress Impairs In Vivo Reendothelialization Capacity of Endothelial Progenitor Cells From Patients With Type 2 Diabetes Mellitus: Restoration by the Peroxisome Proliferator-Activated Receptor-&ggr; Agonist Rosiglitazone (2007) (318)
- Clinical proteomics: A need to define the field and to begin to set adequate standards (2007) (303)
- Recommendations for Biomarker Identification and Qualification in Clinical Proteomics (2010) (298)
- CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease. (2011) (289)
- Stimulation of Endothelial Progenitor Cells: A New Putative Therapeutic Effect of Angiotensin II Receptor Antagonists (2005) (281)
- Advances in urinary proteome analysis and biomarker discovery. (2007) (278)
- Prometheus--a new extracorporeal system for the treatment of liver failure. (2003) (273)
- Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. (2004) (266)
- Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2. (2013) (256)
- Renal function in the elderly: impact of hypertension and cardiac function. (1997) (256)
- Uremia causes endothelial progenitor cell deficiency. (2004) (223)
- Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin Rapid Communication (2003) (221)
- Asymmetrical Dimethylarginine in Idiopathic Pulmonary Arterial Hypertension (2005) (219)
- Renal functional reserve in healthy elderly subjects. (1993) (219)
- The systemic nature of CKD (2017) (218)
- Asymmetric Dimethylarginine, Blood Pressure, and Renal Perfusion in Elderly Subjects (2003) (214)
- Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA (2020) (209)
- Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. (2004) (208)
- ADMA Increases Arterial Stiffness and Decreases Cerebral Blood Flow in Humans (2006) (205)
- Low-Dose Therapy With the Long-Acting Erythropoietin Analogue Darbepoetin Alpha Persistently Activates Endothelial Akt and Attenuates Progressive Organ Failure (2004) (200)
- CE‐MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics (2008) (197)
- FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment. (2010) (197)
- Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. (2011) (195)
- Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers. (2003) (182)
- Monocyte heterogeneity in obesity and subclinical atherosclerosis. (2010) (181)
- Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin. (2003) (174)
- Proteomic analysis for the assessment of diabetic renal damage in humans. (2004) (172)
- Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients (2008) (157)
- Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine (2005) (155)
- Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. (1994) (155)
- Monocyte subpopulations and cardiovascular risk in chronic kidney disease (2012) (149)
- Cardiovascular Disease in Chronic Kidney Disease (2021) (147)
- The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation. (2011) (139)
- Renal findings in patients with short-term type 2 diabetes. (1996) (136)
- Statins attenuate ischemia-reperfusion injury by inducing heme oxygenase-1 in infiltrating macrophages. (2007) (133)
- Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury (2010) (132)
- Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. (2007) (132)
- Coadministration of albumin and furosemide in patients with the nephrotic syndrome. (1999) (131)
- Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4. (2014) (131)
- Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. (2003) (130)
- The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. (2009) (128)
- Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation (2019) (125)
- Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease. (2013) (124)
- Monocyte heterogeneity in human cardiovascular disease. (2012) (123)
- Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk. (2015) (119)
- Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis. (2005) (119)
- B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease Study. (2007) (117)
- Carbamylated low-density lipoprotein induces endothelial dysfunction. (2014) (115)
- No effect of calcitriol on insulin‐mediated glucose uptake in healthy subjects (1997) (115)
- WNT–β-catenin signalling — a versatile player in kidney injury and repair (2020) (115)
- KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease (2018) (114)
- The Agreement between Auscultation and Lung Ultrasound in Hemodialysis Patients: The LUST Study. (2016) (114)
- Pulmonary hypertension in CKD. (2013) (113)
- Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis* (2006) (110)
- Chronic angiotensin II receptor blockade reduces (intra)renal vascular resistance in patients with type 2 diabetes. (2005) (109)
- Circulating long noncoding RNATapSaki is a predictor of mortality in critically ill patients with acute kidney injury. (2014) (107)
- Technology Insight: treatment of renal failure in the intensive care unit with extended dialysis (2006) (106)
- Clinical relevance of FGF-23 in chronic kidney disease. (2009) (105)
- Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans. (1997) (103)
- Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis. (2007) (103)
- Massive analysis of cDNA Ends (MACE) and miRNA expression profiling identifies proatherogenic pathways in chronic kidney disease (2013) (102)
- Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes (2005) (98)
- Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners (1996) (91)
- HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype. (2014) (89)
- Capillary electrophoresis coupled to mass spectrometry to establish polypeptide patterns in dialysis fluids. (2003) (87)
- Combined top-down and bottom-up mass spectrometric approach to characterization of biomarkers for renal disease. (2005) (86)
- Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study. (2006) (86)
- Capillary electrophoresis coupled to mass spectrometer for automated and robust polypeptide determination in body fluids for clinical use (2004) (86)
- Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome (2010) (85)
- Lower Apo A-I and Lower HDL-C Levels Are Associated With Higher Intermediate CD14++CD16+ Monocyte Counts That Predict Cardiovascular Events in Chronic Kidney Disease (2014) (85)
- Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry. (2014) (84)
- HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction. (2014) (84)
- Erythropoietin and renoprotection (2009) (82)
- Renal handling of drugs in the healthy elderly Creatinine clearance underestimates renal function and pharmacokinetics remain virtually unchanged (1999) (82)
- Association between urinary dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort study (2019) (81)
- Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation. (2014) (79)
- Emerging role of post-translational modifications in chronic kidney disease and cardiovascular disease. (2015) (77)
- Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. (2017) (77)
- Asymmetric dimethylarginine (ADMA): the silent transition from an ‘uraemic toxin’ to a global cardiovascular risk molecule (2005) (76)
- Low dialysance of asymmetric dimethylarginine (ADMA)--in vivo and in vitro evidence of significant protein binding. (2004) (76)
- Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis. (2006) (75)
- PROGRESS IN UREMIC TOXIN RESEARCH: Asymmetric Dimethylarginine and Symmetric Dimethylarginine: Axis of Evil or Useful Alliance? (2009) (73)
- Renal resistive index and cardiovascular and renal outcomes in essential hypertension. (2013) (72)
- Circulating angiopoietin-2 levels increase with progress of chronic kidney disease. (2010) (71)
- Hypertension in Chronic Kidney Disease Part 2: Role of Ambulatory and Home Blood Pressure Monitoring for Assessing Alterations in Blood Pressure Variability and Blood Pressure Profiles (2016) (71)
- Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin (2009) (71)
- BK Polyomavirus‐Specific Cellular Immune Responses Are Age‐Dependent and Strongly Correlate With Phases of Virus Replication (2014) (69)
- Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS) (2014) (69)
- Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure (2003) (68)
- Subpressor Dose Asymmetric Dimethylarginine Modulates Renal Function in Humans through Nitric Oxide Synthase Inhibition (2004) (68)
- Tubular Dickkopf-3 promotes the development of renal atrophy and fibrosis. (2016) (67)
- The Prometheus® Device for Extracorporeal Support of Combined Liver and Renal Failure (2005) (66)
- Kidney Graft Function Determines Endothelial Progenitor Cell Number in Renal Transplant Recipients (2005) (64)
- Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease. (2010) (63)
- Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease (2017) (62)
- Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia/reperfusion-injury (2018) (61)
- FGF-23: the rise of a novel cardiovascular risk marker in CKD. (2012) (60)
- Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing extended daily dialysis. (2008) (60)
- EPO: renoprotection beyond anemia correction (2006) (59)
- Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients (2012) (59)
- ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease? (2001) (58)
- Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease (2010) (58)
- Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss. (2018) (58)
- Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario? (2014) (57)
- Assessment of renal function in elderly patients (2008) (56)
- The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda (2011) (56)
- Hypertension in Chronic Kidney Disease Part 1: Out-of-Office Blood Pressure Monitoring Methods, Thresholds, and Patterns (2016) (55)
- Dimethylarginines ADMA and SDMA: the real water-soluble small toxins? (2014) (54)
- Insulin action and non-esterified fatty acids (1997) (54)
- Renal function in the elderly--is the dogma of an inexorable decline of renal function correct? (1997) (54)
- Osteopontin predicts survival in critically ill patients with acute kidney injury. (2011) (54)
- The effect of dietary salt on insulin sensitivity (1995) (53)
- Efficacy of a remote web-based lung ultrasound training for nephrologists and cardiologists: a LUST trial sub-project. (2016) (51)
- The Relationships of Markers of Cholesterol Homeostasis with Carotid Intima-Media Thickness (2010) (51)
- Vascular endothelial damage and repair in antineutrophil cytoplasmic antibody-associated vasculitis. (2007) (50)
- The continuous erythropoietin receptor activator affects different pathways of diabetic renal injury. (2007) (50)
- Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow—implications for CKD and cardiovascular disease (2011) (50)
- Removal selectivity of Prometheus: a new extracorporeal liver support device. (2006) (49)
- Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease (2018) (49)
- SuperTAG Methylation-specific Digital Karyotyping Reveals Uremia-induced Epigenetic Dysregulation of Atherosclerosis-Related Genes (2012) (48)
- Immunosuppression and monocyte subsets. (2015) (48)
- High-flux hemodialysis--an effective alternative to hemoperfusion in the treatment of carbamazepine intoxication. (2002) (48)
- Angiotensin II receptor blocker and statins lower elevated levels of osteopontin in essential hypertension--results from the EUTOPIA trial. (2010) (47)
- The Circular RNA ciRs-126 Predicts Survival in Critically Ill Patients With Acute Kidney Injury (2018) (47)
- Effects of asymmetric dimethylarginine (ADMA) infusion in humans (2006) (47)
- Asymmetric dimethylarginine: a cardiovascular risk factor in renal disease? (2003) (47)
- Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link? (2011) (47)
- Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis (2012) (46)
- [Nephropathy in type 2 diabetes mellitus]. (2000) (46)
- Stem cells and progenitor cells in renal disease. (2005) (45)
- Angiotensin II enhances insulin sensitivity in healthy volunteers under euglycemic conditions (1993) (45)
- FGF-23 is associated with increased disease severity and early mortality in cardiogenic shock (2013) (45)
- HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney Disease. (2017) (44)
- T-cell Numbers and Antigen-specific T-cell Function Follow Different Circadian Rhythms (2012) (44)
- Mild cognitive impairment and kidney disease: clinical aspects. (2019) (44)
- A single-pass batch dialysis system: an ideal dialysis method for the patient in intensive care with acute renal failure (2004) (43)
- Calcium and phosphate impact cardiovascular risk. (2013) (43)
- Cholesterol synthesis, cholesterol absorption, and mortality in hemodialysis patients. (2012) (43)
- Perspectives in renal disease progression: the endothelium as a treatment target in chronic kidney disease. (2010) (42)
- The CKD Outcomes and Practice Patterns Study (CKDopps): Rationale and Methods. (2016) (42)
- The past, presence and future of ADMA in nephrology. (2007) (41)
- High-dose erythropoietin has no effect on short- or long-term graft function following deceased donor kidney transplantation. (2012) (41)
- Erythropoietin and treatment of non-anemic conditions--cardiovascular protection. (2007) (40)
- Uraemic dyslipidaemia revisited: role of high-density lipoprotein. (2013) (40)
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality. (2021) (40)
- Endothelial Progenitor Cells and Cardiovascular Events in Patients with Chronic Kidney Disease – a Prospective Follow-Up Study (2010) (40)
- Erythropoietin: is it more than correcting anaemia? (2004) (40)
- Relationship between Hypertension and Renal Function and Its Therapeutic Implications in the Elderly (1998) (39)
- Type II diabetes mellitus: is the renal risk adequately appreciated? (1991) (39)
- Pathophysiology of hypertensive renal damage. (1993) (38)
- Comparison of two different strategies for human monocyte subsets gating within the large‐scale prospective CARE FOR HOMe Study (2015) (38)
- Ren sanus in corpore sano: the myth of the inexorable decline of renal function with senescence. (2005) (38)
- PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR (2016) (38)
- Evaluation of maintenance of stable haemoglobin levels in haemodialysis patients converting from epoetin or darbepoetin to monthly intravenous C.E.R.A.: the MIRACEL study (2010) (38)
- Mechanisms of Disease: erythropoietin—an old hormone with a new mission? (2006) (37)
- High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney disease. (2015) (36)
- Efficiency of High‐Flux Hemodialysis in the Treatment of Valproic Acid Intoxication (2003) (36)
- Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction (2017) (35)
- Ultrasound renal resistive index is not an organ-specific predictor of allograft outcome. (2012) (34)
- Distinct immunologic effects of different intravenous iron preparations on monocytes (2014) (34)
- Haemodialysis-induced transient CD16+ monocytopenia and cardiovascular outcome. (2009) (34)
- Innate immunity in CKD-associated vascular diseases. (2016) (33)
- Angiotensin II affects basal, pulsatile, and glucose-stimulated insulin secretion in humans. (1997) (33)
- Monocyte angiotensin converting enzyme expression may be associated with atherosclerosis rather than arteriosclerosis in hemodialysis patients. (2011) (32)
- DNA methylation profiling reveals differences in the 3 human monocyte subsets and identifies uremia to induce DNA methylation changes during differentiation (2016) (31)
- The sympathetic nervous system and the kidney: its importance in renal diseases. (1998) (31)
- Angiotensin II Affects Basal, Pulsatile, and Glucose-Stimulated Insulin Secretion in Humans (1997) (31)
- Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials. (2019) (30)
- Everolimus-associated interstitial pneumonitis in a patient with a heart transplant. (2007) (30)
- Two Cardiovascular Risk Factors in One? Homocysteine and Its Relation to Glomerular Filtration Rate (2008) (30)
- S-adenosylhomocysteine is associated with subclinical atherosclerosis and renal function in a cardiovascular low-risk population. (2014) (29)
- Chronic kidney disease progression and mortality risk profiles in Germany: results from the Chronic Kidney Disease Outcomes and Practice Patterns Study (2020) (29)
- Insulin resistance in CKD. (2014) (29)
- Changes in plasma phosphate levels influence insulin sensitivity under euglycemic conditions. (1996) (29)
- Endothelial progenitor cells in chronic kidney disease. (2010) (29)
- A randomized multicenter trial on a lung ultrasound guided treatment strategy in patients on chronic hemodialysis with high cardiovascular risk. (2021) (28)
- External Validation of the Kidney Failure Risk Equation and Re-Calibration with Addition of Ultrasound Parameters. (2016) (28)
- Opposing effects of angiotensin II on muscle and renal blood flow under euglycemic conditions. (2000) (28)
- Implementation and first results of a German chronic kidney disease registry. (2013) (28)
- PROGRESS IN UREMIC TOXIN RESEARCH: The Role of EUTox in Uremic Toxin Research (2009) (28)
- Erythropoietin and progression of CKD. (2007) (27)
- Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD. (2015) (27)
- How can we improve prognosis in diabetic patients with end-stage renal disease? (1999) (26)
- Proteinuria and hypertension. (1994) (26)
- Renal reserve in the elderly. (1995) (25)
- NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4. (2016) (25)
- Associations of Hemoglobin Levels With Health-Related Quality of Life, Physical Activity, and Clinical Outcomes in Persons With Stage 3-5 Nondialysis CKD. (2020) (25)
- Serum lipid changes on low salt diet. Effects of alpha 1-adrenergic blockade. (1993) (25)
- Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus®) (2006) (25)
- Does the measurement of the difference of resistive indexes in spleen and kidney allow a selective assessment of chronic kidney injury? (2012) (25)
- HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients[S] (2018) (24)
- Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease. (2018) (24)
- Renal haemodynamics in the elderly. (1996) (24)
- Prescription of renin‐angiotensin‐aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care (2019) (24)
- MicroRNA profiling of human intermediate monocytes. (2017) (23)
- Bardoxolone methyl, chronic kidney disease, and type 2 diabetes. (2011) (23)
- Dosing strategies for conversion of haemodialysis patients from short‐acting erythropoiesis stimulating agents to once‐monthly C.E.R.A.: experience from the MIRACEL study (2011) (23)
- Functional changes in the ageing kidney: is there a role for asymmetric dimethylarginine? (2003) (23)
- Systems biology to battle vascular disease. (2010) (23)
- Erythropoietin Prevents Diabetes-Induced Podocyte Damage (2008) (22)
- Validity of Vascular Calcification as a Screening Tool and as a Surrogate End Point in Clinical Research. (2015) (22)
- ERA-EDTA invests in transformation to greener health care. (2018) (22)
- Consequences of chronic kidney disease in chronic obstructive pulmonary disease (2019) (22)
- The complexity of the cardio–renal link: taxonomy, syndromes, and diseases (2011) (21)
- Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus). (2006) (21)
- Dickkopf 3-a novel biomarker of the 'kidney injury continuum'. (2020) (21)
- TLR-4+ peripheral blood monocytes and cardiovascular events in patients with chronic kidney disease--a prospective follow-up study. (2011) (21)
- Frequency and clinical influence of lymphoceles after kidney transplantation. (1990) (20)
- A single preoperative FGF23 measurement is a strong predictor of outcome in patients undergoing elective cardiac surgery: a prospective observational study (2015) (20)
- Cellular and molecular mechanisms of tissue protection by lipophilic calcium channel blockers (2006) (20)
- Toll-Like Receptor 2 and Renal Allograft Function (2008) (19)
- Lipoproteins in chronic kidney disease: from bench to bedside. (2021) (19)
- Insulin resistance and renal disease. (2006) (19)
- Insulin action and non-esterified fatty acids. The European Group for the Study of Insulin Resistance (EGIR). (1997) (19)
- One for All – A Multi-Use Dialysis System for Effective Treatment of Severe Thallium Intoxication (2004) (18)
- Wormwood (Artemisia absinthium) for poorly responsive early-stage IgA nephropathy: a pilot uncontrolled trial. (2010) (18)
- Impact of individual intravenous iron preparations on the differentiation of monocytes towards macrophages and dendritic cells (2016) (18)
- Erythropoiesis-stimulating agents: past and future. (2007) (18)
- Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University (2018) (17)
- Altered action of angiotensin II in patients with type 2 diabetes mellitus of recent onset (1997) (17)
- Erythropoietin and the endothelium – a promising link? (2008) (17)
- Indices of systemic atherosclerosis are superior to ultrasound resistance indices for prediction of allograft survival. (2010) (16)
- Do plasma neprilysin activity and plasma neprilysin concentration predict cardiac events in chronic kidney disease patients? (2019) (16)
- Plasma levels of the oxyphytosterol 7α-hydroxycampesterol are associated with cardiovascular events. (2018) (16)
- Changes in plasma amino acids during extracorporeal liver support by fractionated plasma separation and adsorption. (2010) (15)
- Proprotein convertase subtilisin/kexin type 9 in kidney disease. (2019) (15)
- Efficacy and safety of anticoagulation with heparin versus heparin plus epoprostenol in patients undergoing extracorporeal liver support with Prometheus. (2010) (15)
- Single FGF-23 measurement and time-averaged plasma phosphate levels in hemodialysis patients. (2013) (15)
- Mortality and Cardiovascular Morbidity Associated with Haemoglobin Levels: A Pooled Analysis of Randomised Controlled Trials (2014) (14)
- The use of echocardiography in observational clinical trials: the EURECA-m registry. (2013) (14)
- Albuminuria of hypertensive patients. (1992) (13)
- Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose—the randomized controlled HOMe aFers study (2020) (13)
- Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients (2015) (13)
- Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment (2019) (13)
- Interleukin-1α Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease (2021) (13)
- Use of argatroban: experiences in continuous renal replacement therapy in critically ill patients after cardiac surgery. (2014) (13)
- The gap between calculated and actual calcium substitution during citrate anticoagulation in an immobilised patient on renal replacement therapy reflects the extent of bone loss – a case report (2014) (13)
- Low serum lathosterol levels associate with fatal cardiovascular disease and excess all-cause mortality: a prospective cohort study (2019) (12)
- Association of vascular endothelial factors with cardiovascular outcome and mortality in chronic kidney disease patients: a 4-year cohort study. (2014) (12)
- The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation incorporating both cystatin C and creatinine best predicts individual risk: a cohort study in 444 patients with chronic kidney disease. (2014) (12)
- Therapeutic apheresis within immune-mediated neurological disorders: dosing and its effectiveness (2020) (12)
- Successful outcome of kidney transplantation from a HBV-DNA positive donor into recipients with cleared HBV-infection using a pre-emptive therapy approach. (2010) (12)
- Treatment with high doses of loop diuretics in chronic renal failure. (1994) (11)
- The kidney in congestive heart failure. (1991) (11)
- Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy (2016) (11)
- Major pathways of the reno–cardiovascular link: the sympathetic and renin–angiotensin systems (2011) (11)
- Cholesteryl ester transfer protein activity and cardiovascular events in patients with chronic kidney disease stage V. (2008) (11)
- Response to Letter Regarding Article, “Oxidant Stress Impairs In Vivo Reendothelialization Capacity of Endothelial Progenitor Cells From Patients With Type 2 Diabetes Mellitus: Restoration by the Peroxisome Proliferator- Activated Receptor-γ Agonist Rosiglitazone” (2008) (10)
- Reduction of protein‐bound uraemic toxins in plasma of chronic renal failure patients: A systematic review (2021) (10)
- How many patients with renal insufficiency survive until end-stage renal failure? (1991) (10)
- l-Homoarginine and its AGXT2-metabolite GOCA in chronic kidney disease as markers for clinical status and prognosis (2018) (10)
- Right-sided chest pain at the onset of haemodialysis. (2001) (10)
- Effects of acute ACE inhibition on pulsatile renin and aldosterone secretion and their synchrony. (1998) (10)
- Orphan nuclear receptor ERR-γ regulates hepatic FGF23 production in acute kidney injury (2021) (10)
- Targeting innate immunity-driven inflammation in CKD and cardiovascular disease (2022) (10)
- [Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology]. (2017) (9)
- Removal of asymmetric dimethylarginine during artificial liver support using fractionated plasma separation and adsorption (2010) (9)
- Biocompatibility Parameters of Different Dialysis Membranes Assessed during Systemic Inflammation (2005) (9)
- The fate of triaged and rejected manuscripts. (2015) (9)
- Chronic erythropoietin treatment affects different molecular pathways of diabetic cardiomyopathy in mouse (2009) (9)
- Kinetic Changes of Plasma Renin Levels Predict Acute Kidney Injury in Cardiac Surgery Patients. (2020) (9)
- Validation of echocardiographic criteria for the clinical diagnosis of heart failure in chronic kidney disease (2018) (9)
- The new SFB/TRR219 Research Centre. (2018) (9)
- Proteinuria as a function of hypertension and age. (1993) (9)
- A hibernating kidney - ischemic preconditioning in a renal transplant recipient with a proximal stenosis of the iliac artery. (2008) (9)
- Early low‐dose erythropoiesis‐stimulating agent therapy and progression of moderate chronic kidney disease: a randomized, placebo‐controlled trial (2017) (8)
- Measurement of serum soluble Klotho levels in CKD 5D patients: useful tool or dispensable biomarker? (2012) (8)
- Klotho Deficiency and the Cardiomyopathy of Advanced CKD. (2015) (8)
- Plasma FGF23 does not rise during physical exercise as a physiological model of sympathetic activation (2018) (8)
- Influence of ACE inhibition on glucose tolerance in patients with stable chronic renal failure. (1995) (8)
- Loop diuretics and thiazides--the case for their combination in chronic renal failure. (1996) (8)
- Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe (2019) (8)
- Hypertension and the kidney--an overview. (1993) (8)
- Does essential hypertension cause progressive renal disease? (1998) (8)
- Effect of moxonidine on urinary electrolyte excretion and renal haemodynamics in man (2004) (7)
- The Primavera study protocol design: evaluating the effect of continuous erythropoiesis receptor activator (C.E.R.A.) on renal function in non-anemic patients with chronic kidney disease. (2011) (7)
- [Fulminant course of leptospirosis complicated by multiple organ failure]. (2001) (7)
- Pharmacokinetics and pharmacodynamics of lisinopril in advanced renal failure (1994) (7)
- Once-Monthly Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III Trials (2016) (7)
- Effective Achievement of Hemoglobin Stability with Once-Monthly C.E.R.A. in Peritoneal Dialysis Patients: A Prospective Study (2013) (7)
- Guanidinylated Apolipoprotein C3 (ApoC3) Associates with Kidney and Vascular Injury (2021) (7)
- Renal function and fluid-electrolyte homeostasis changes with age (1993) (7)
- Adherence to the Kidney Disease: Improving Global Outcomes CKD Guideline in Nephrology Practice Across Countries (2020) (7)
- Comparison of the performance of 2 GFR estimating equations using creatinine and cystatin C to predict adverse outcomes in elderly individuals. (2015) (7)
- Adherence to the Kidney Disease: Improving Global Outcomes CKD Guideline in Nephrology Practice Across Countries (2020) (7)
- What should European nephrology do with the new CKD-EPI equation? (2022) (7)
- CARDIOVASCULAR EFFECTS OF SYSTEMIC NITRIC OXIDE SYNTHASE INHIBITION WITH ASYMMETRIC DIMETHYLARGININE IN HUMANS: P 061 (2004) (6)
- The lingering dilemma of arterial pressure in CKD: what do we know, where do we go? (2011) (6)
- The ERA-EDTA today and tomorrow: a progress document by the ERA-EDTA Council. (2018) (6)
- Adherence to the KDIGO Chronic Kidney Disease Guideline in Nephrology Practice across Countries (2020) (6)
- Measurement of urinary Dickkopf-3 uncovered silent progressive kidney injury in patients with chronic obstructive pulmonary disease. (2021) (6)
- Hypophosphatemia after High Dosage Iron Substitution with Ferric Carboxymaltose (FCM) and Iron Isomaltoside (IM) — the Randomised Controlled Home Afers 1 Trial (2018) (6)
- Cardiovascular disease in renal patients--a matter of stem cells? (2004) (6)
- Best Albuminuria Measurement to Predict Cardiovascular and Renal Events (2016) (6)
- Kidney transplantation from a deceased donor with anuric acute kidney injury caused by rhabdomyolysis. (2014) (5)
- Lancet Countdown paper: what does it mean for nephrology? (2018) (5)
- Prometheus — A new extracorporeal device for the treatment of liver failure (2003) (5)
- Does a rise in plasma erythropoietin after high-altitude exposure affect FGF23 in healthy volunteers on a normal or low-phosphorus diet? (2019) (5)
- Effects of angiotensin-converting enzyme inhibition on renal sodium handling after furosemide injection (1993) (5)
- Pathophysiology and treatment of hypertension and oedema due to renal failure. (1994) (5)
- A novel adaptation of laparoscopic Tenckhoff catheter insertion technique to enhance catheter stability and function in automated peritoneal dialysis (2014) (5)
- CD 14 11 CD 16 1 monocytes and cardiovascular outcome in patients with chronic kidney disease (2010) (5)
- Sunday, 26 August 2012 (2012) (5)
- Lowering Asymmetric Dimethylarginine – A New Mechanism Mediating the Renoprotective Effects of Renin-Angiotensin System Inhibitors in Proteinuric Patients? (2007) (5)
- Differential effects of ACE inhibitors and vasodilators on renal function curve in patients with primary hypertension. (1993) (4)
- EDTAKI: A Nephrology and Public Policy Committee (NPPC) Platform Call for More European Involvement in AKI. (2021) (4)
- The plasticity of progenitor cells--why is it of interest to the nephrologists? (2009) (4)
- Immune-based guidance of foscarnet treatment duration in a transplant recipient with ganciclovir-resistant cytomegalovirus infection. (2016) (4)
- Nephrology: achieving sustainability. (2020) (4)
- Funding kidney research as a public health priority: challenges and opportunities. (2020) (4)
- Kidney disease 1 Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure (2014) (4)
- Donor‐specific alloreactive T cells can be quantified from whole blood, and may predict cellular rejection after renal transplantation (2017) (4)
- Prevention of vascular calcification by the endogenous chromogranin A-derived mediator that inhibits osteogenic transdifferentiation (2021) (3)
- The nephrology crystal ball: the medium-term future. (2019) (3)
- Reprint of: MicroRNA profiling of human intermediate monocytes. (2017) (3)
- Mycobacterium fortuitum peritonitis in peritoneal dialysis and its effects on the peritoneum. (2014) (3)
- Monday, 27 August 2012 (2012) (3)
- [Modern differential therapy with diuretics]. (2004) (3)
- Clinical relevance of albuminuria in hypertensive patients (2004) (3)
- Promoting scientific collaboration and education in cardiovascular–renal medicine (2009) (3)
- Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study (2020) (2)
- Markers of cholesterol synthesis to cholesterol absorption across the spectrum of non‐dialysis CKD: An observational study (2021) (2)
- Risk Factors for Progression of Chronic Kidney Disease (2009) (2)
- "Chronic kidney disease - mineral bone disorder" (CKD-MBD) (2015) (2)
- The Hannover Dialysis Outcome (HAN-D-OUT) study: comparison of standard versus intensified dialysis in treatment of patients with acute kidney injury in the ICU (2008) (2)
- Alloreactive T Cells to Identify Risk HLA Alleles for Retransplantation After Acute Accelerated Steroid-Resistant Rejection. (2015) (2)
- DIALYSIS BONE DISEASE (2014) (2)
- Niere und Hypertonie (2006) (2)
- Precision medicine in diabetic nephropathy and chronic kidney disease. (2021) (2)
- [Disorders of calcium and phosphate homeostasis]. (1999) (2)
- Angiotensin II subtype 1‐receptor antagonists in the treatment of diabetic nephropathy (2001) (2)
- Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe (2019) (2)
- OACE inhibition does not interfere with acute extrarenal or renal potassium disposal in chronic renal failure (2004) (2)
- Effect of experimental hyperglycaemia on renal haemodynamics in prediabetic patients with and without AT1 receptor blockade (2010) (2)
- Lab methods / biomarkers (2013) (1)
- [Chronic kidney disease-a cardiovascular high-risk constellation]. (2019) (1)
- Inhibition of Complement Activation with EDTA in Vivo during Sham Hemodialysis (1991) (1)
- Renal anaemia - CKD 1-5 (2012) (1)
- Minimal cognitive impairment and kidney disease : clinical aspects (2019) (1)
- Renal replacement therapy in the intensive care unit with a single-pass batch system. (2002) (1)
- Are newer antihypertensive agents really more effective than traditional drugs in progressive renal disease? (1991) (1)
- Extended Daily Dialysis (2010) (1)
- Erratum: Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe (Nephrology Dialysis Transplantation (2019) (gfz089) DOI: 10.1093/NDT/gfz089) (2019) (1)
- T-cell Numbers and Antigen-specific T-cell Function Follow Different Circadian Rhythms (2012) (1)
- [Acute renal failure. Extracorporeal therapy]. (2007) (1)
- Impaired in vivo reendothelialization capacity of endothelial progenitor cells of patients with type-2 diabetes is restored by PPAR-gamma agonist rosiglitazone: Role of NAD(P)H oxygenase and nitric oxide (2006) (1)
- CKD GENERAL AND CLINICAL EPIDEMIOLOGY 1 (2014) (1)
- Does occupational exposure to toxins increase albumin excretion rate? (1998) (1)
- Angiotensin converting enzyme inhibitors and nephroprotection (1995) (1)
- Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia/reperfusion-injury (2018) (1)
- [Nephroprotection with ACE inhibitors]. (1991) (1)
- [Kidney and hypertension]. (2006) (1)
- Do sea stars have low ADMA levels? High ADMA and low EPC count--duo infernal for the kidney. (2010) (1)
- Urinary DKK3 and the evaluation of chronic kidney disease progression. (2021) (1)
- Erratum to Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials (2019) (1)
- The ERA-EDTA today and tomorrow: a progress document by the ERA-EDTA Council (2018) (1)
- Endstage renal failure in diabetes type II ‐ a silent epidemic (1998) (1)
- Urinary DKK3 as a biomarker for short-term kidney function decline in children with chronic kidney disease: an observational cohort study. (2023) (1)
- Abstract 18317: Abnormal High Density Lipoprotein (HDL) from Patients with Chronic Kidney Disease (CKD) Increases Arterial Blood Pressure: Role of Toll-Like Receptor-2 (TLR-2) (2012) (1)
- Lipids and other risk factors (2013) (1)
- PROGRESS IN UREMIC TOXIN RESEARCH: Conservative Treatment of the Uremic Syndrome (2009) (1)
- Potential Surrogate Outcomes for Kidney Failure in Advanced CKD: Evaluation of Power and Predictive Ability in CKDopps (2021) (1)
- Potential Surrogate Outcomes for Kidney Failure in Advanced CKD: Evaluation of Power and Predictive Ability in CKDopps (2021) (1)
- BK Virus-Specific Immune Responses Are Age-Dependent and Strongly Correlate with Phases of Virus Replication: 1898 (2012) (1)
- Ferric pyrophosphate: good things come to those who wait? (2015) (1)
- FP346CKD PROGRESSION IN GERMANY (2018) (1)
- Clinical Nephrology - Lab methods and other markers (2012) (1)
- Abstract 1929: Endogenous Cholesterol Synthesis Is Associated With Increased Carotid Intima-Media-Thickness (2008) (1)
- Erythropoietin counteracts the renal hemodynamic effects of ADMA (2006) (1)
- [The metabolic syndrome]. (1995) (0)
- Bone and mineral diseases - 2 (2012) (0)
- Plasma biomarkers outperform echocardiographic measurements for cardiovascular risk prediction in kidney transplant recipients: results of the HOME ALONE study (2021) (0)
- FP377ASSOCIATION OF OUTCOMES AND HB LEVELS IN CKD PATIENTS: FINDINGS FROM A POOLED ANALYSIS OF 24 PROSPECTIVE STUDIES (2015) (0)
- Cardiovascular complications in CKD 5D (2012) (0)
- B-Type Natriuretic Peptide Concentrations Predict the Progression of Nondiabetic Chronic Kidney Disease: The Mild-to-Moderate Kidney Disease Study and (2007) (0)
- Transplantation / Basic research (2011) (0)
- SaO038PREOPERATIVE URINARY DICKKOPF-3 (DKK3) PREDICTS POSTOPERATIVE ACUTE KIDNEY INJURY AND TRANSITION INTO CKD IN PATIENTS UNDERGOING CARDIAC SURGERY (2019) (0)
- SP546DISTINCT IN VIVO IMMUNOLOGIC EFFECTS OF IRON SUCROSE AND IRON ISOMALTOSIDE 1000 ON MONOCYTES (2016) (0)
- MARKERS FOR CHOLESTEROL METABOLISM AND OUTCOMES IN PATIENTS WITH CHRONIC KIDNEY DISEASE (2020) (0)
- P6434Low serum lathosterol levels predict fatal cardiovascular disease and all cause mortality: a prospective cohort study in patients admitted for coronary angiography (2018) (0)
- Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation (2019) (0)
- P0676CHOLESTEROL ABSORPTION JUGDED BY CAMPESTEROL / LATHOSTEROL RATIO AND OUTCOMES IN CHRONIC KIDNEY DISEASE (2020) (0)
- Epidemiology - renal outcomes (2013) (0)
- Renal pressure-natriuresis relationship. (1993) (0)
- 457 DIFFERENTIAL EFFECTS OF IMMUNOSUPPRESSIVE DRUGS ON REGULATORY T-CELL FUNCTION (2010) (0)
- FO084APOLIPOPROTEIN C3 INDUCES SYSTEMIC INFLAMMATION AND ORGAN DAMAGE IN CKD BY ALTERNATIVE INFLAMMASOME ACTIVATION VIA A NOVEL PATHWAY (2019) (0)
- SP280HIGH-DENSITY LIPOPROTEIN - SYMMETRIC DIMETHYLARGININE - A CKD-SPECIFIC ASSOCIATION PROMOTING PREMATURE CARDIOVASCULAR DISEASE (2016) (0)
- [The kidneys and old age]. (2008) (0)
- Does the measurement of the difference of resistive indices in spleen and kidney (DI-RISK) allow a selective assessment of chronic kidney injury? (2012) (0)
- Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients (2015) (0)
- MO031APOLIPOPROTEIN C3 INDUCES SYSTEMIC INFLAMMATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE BY ACTIVATING THE NALP3 INFLAMMASOME VIA A NOVEL MOLECULAR PATHWAY (2017) (0)
- MO056CTERMINAL FGF23 VERSUS INTACT FGF23 AS CARDIOVASCULAR PREDICTOR IN CHRONIC KIDNEY DISEASE (2017) (0)
- Cardiovascular complications - 2 (2009) (0)
- Present and future of CONNECT: a new and compelling project of modern medicine (2021) (0)
- P127 MARKERS OF CHOLESTEROL METABOLISM ARE ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESS (2010) (0)
- TREATMENT WITH THE CALCIUM CHANNEL ANTAGONIST LERCANIDIPINE MODULATES ASYMMETRIC DIMETHYLARGININE (ADMA): P3.152 (2004) (0)
- CLINICAL ACUTE KIDNEY INJURY 2 (2014) (0)
- [Not Available]. (2015) (0)
- Real-Life Anemia Management Among Patients with Non-Dialysis-Dependent Chronic Kidney Disease in Three European Countries. (2023) (0)
- The need for a multi-disciplinary reflection about frailty and cognitive impairment in chronic kidney disease (2022) (0)
- FC 066DICKKOPF-3 (DKK3) LINKS RECIPROCAL LUNG AND KIDNEY INJURY IN MICE AND HUMANS (2021) (0)
- SO003LIFE-LONG NLRP3 INFLAMMASOME-MEDIATED SYSTEMIC INFLAMMATION ASSOCIATES WITH CARDIOVASCULAR MORTALITY: A GENETIC ASSOCIATION STUDY OF >500,000 INDIVIDUALS (2020) (0)
- THE CALCIUM CHANNEL ANTAGONIST LERCANIDIPINE REDUCES INFLAMMATION MARKERS AND PROLONGS SURVIVAL: P3.156 (2004) (0)
- Pathophysiology and clinical studies in CKD 5D (2011) (0)
- A material stress test study on occurrence of leakage and material failure of peritoneal dialysis (PD) catheters (2021) (0)
- LB06DKK3 IN URINE IDENTIFIES PATIENTS WITH PROGRESSIVE CHRONIC KIDNEY DISEASE (2018) (0)
- [Disorders of calcium and phosphate homeostasis]. (1998) (0)
- Reply to: Apolipoprotein C3 induces inflammasome activation only in its delipidated form (2023) (0)
- A database of naturally occurring human urinary peptides and proteins for use in clinical applications (2007) (0)
- FP266GROWTH DIFFERENTIATION FACTOR 15 IS A NOVEL BIOMARKER FOR PREDICTION OF RENAL OUTCOMES IN CHRONIC KIDNEY DISEASE (2015) (0)
- SP354PREDICTORS OF RENAL ANEMIA AND EPOETIN BIOSIMILAR THERAPY IN GERMAN HEMODIALYSIS PATIENTS (2018) (0)
- Management of Essential Hypertension (2009) (0)
- MO451GUANIDINYLATED APOLIPOPROTEIN C3 (APOC3) A NOVEL PLAYER IN CKD AND CKD-ASSOCIATED CARDIOVASCULAR DISEASES (2021) (0)
- SO080NOVEL EVIDENCE OF THE “PULMO-RENAL INTERACTION” AS A DISEASE DRIVER IN PATIENTS WITH CKD AND COPD (2020) (0)
- INFLUENCE OF ACE INHIBITION ON INSULIN RESISTANCE. AUTHORS' REPLY (1995) (0)
- TO012 DYSFUNCTIONAL HIGH-DENSITY LIPOPROTEIN (HDL) IN CHRONIC KIDNEY DISEASE (CKD): A PROSPECTIVE OBSERVATIONALTRIALOF 3.306 PATIENTS (2013) (0)
- CKD LAB METHODS, PROGRESSION & RISK FACTORS 2 (2014) (0)
- CKD NUTRITION, INFLAMMATION AND OXIDATIVE STRESS (2014) (0)
- SP340CHANGES IN FGF-23 PLASMA-LEVELS BEFORE AND AFTER SUCCESSFUL ELECTRIC CARDIOVERSION IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION (2015) (0)
- Contents Vol. 31, 2008 (2008) (0)
- MP407 THE RELATIONSHIP BETWEEN PHYSICAL ACTIVITY STATUS AND SERUM IRISIN AND MYOSTATIN LEVELS _ IN PATIENTS WITH NON-DIALYSIS CHRONIC KIDNEY DISEASE (2017) (0)
- HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients patient-oriented and epidemiological (2020) (0)
- SP259IRON DEFICIENCY AND FGF 23 IN CHRONIC KIDNEY DISEASE (2018) (0)
- 259 REMOVAL OF ASYMMETRIC DIMETHYLARGININE (ADMA) DURING ARTIFICIAL LIVER SUPPORT USING FRACTIONATED PLASMA SEPARATION AND ADSORPTION (PROMETHEUS (2008) (0)
- SP317ARE ACETYLATED DIMETHYLARGININES INDENPENDENT CARDIOVASCULAR RISK FACTORS IN CKD PATIENTS (2017) (0)
- Therapierichtlinien@@@Therapy guidelines (2008) (0)
- [Inhibition of the progression of renal failure in glomerular diseases]. (1993) (0)
- MO470PATIROMER PHARMACOUTILIZATION IN REAL-WORLD GERMAN CKD PATIENTS WITH MODERATELY TO SEVERELY REDUCED EGFR (2021) (0)
- FP231GATING STRATEGY FOR THE IDENTIFICATION OF INTERMEDIATE MONOCYTES IN PATIENTS WITH CHRONIC KIDNEY DISEASE (2015) (0)
- CTERMINAL FGF23 VERSUS INTACT FGF23 AS CARDIOVASCULAR PREDICTOR IN CHRONIC KIDNEY DISEASE (2017) (0)
- Section Review: Cardiovascular & Renal: Angiotensin converting enzyme inhibitors and nephroprotection (1995) (0)
- FP378ASSOCIATION OF OUTCOMES AND MAINTENANCE OF TARGET HB LEVELS IN CKD PATIENTS: FINDINGS FROM A POOLED ANALYSIS OF 23 PROSPECTIVE STUDIES (2015) (0)
- [Current therapy of chronic kidney insufficiency]. (1991) (0)
- Attenuated metabolic and increased renal effects of angiotensin II (ang II) in early type 2 diabetes mellitus (NIDDM) (1997) (0)
- Subject Index Vol. 31, 2008 (2008) (0)
- FO005SERUM AMYLOID A (SAA) AND HIGH DENSITY LIPOPROTEINS (HDL) INTERACTION AND CARDIOVASCULAR RISK IN RENAL PATIENTS (2015) (0)
- Akutes Nierenversagen (2011) (0)
- MP450PLASMA EXCHANGE AND IMMUNOADSORPTION IN NEUROLOGICAL DISEASES. WHAT ABOUT THE DOSE FOR APHERESIS (2016) (0)
- Tissue Protection and Regeneration Aided by Erythropoietin and Erythropoietin-derived Peptides (2011) (0)
- Nephropathy in NIDDM — an update (1998) (0)
- Contents Vol. 128, 2014 (2015) (0)
- Akute interstitielle Nephritis (2014) (0)
- Abnormal endothelial vasomotor and secretory function (2015) (0)
- MP354SYMMETRIC DIMETHYLARGININE, HIGH-DENSITY LIPOPROTEINS AND CARDIOVASCULAR DISEASE (2017) (0)
- Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients (2019) (0)
- [Regeneration of renal tissue -- therapy of the future?]. (2006) (0)
- [Protein restriction in chronic kidney insufficiency]. (1991) (0)
- Patiromer utilization in patients with advanced chronic kidney disease under nephrology care in Germany (2022) (0)
- MP409VARIATION IN RENIN ANGIOTENSIN ALDOSTERONE SYSTEM INHIBITOR (RAASi) PRESCRIPTION INTERNATIONALLY AND ACROSS CKD STAGES (2017) (0)
- CELL SIGNALLING AND APOPTOSIS (2014) (0)
- MO004UREMIA INDUCES DIFFERENTIATION OF PROATHEROGENIC MONOCYTES VIA DNA HYPOMETHYLATION (2016) (0)
- MO453: Post-Translational Guanidinylation of Apolipoprotein C3 (APOC3) is Associated With Kidney and Vascular Injury (2022) (0)
- [Chronic renal failure after acute kidney injury]. (2013) (0)
- [Biomarkers in acute kidney failure]. (2013) (0)
- Supplementary Material for: Best Albuminuria Measurement to Predict Cardiovascular and Renal Events (2016) (0)
- Markers for cholesterol metabolism and cardiovascular outcomes in patients with chronic kidney disease (2020) (0)
- Safety of Argatroban in critically ill patients with acute kidney injury and renal replacement therapy after cardiac surgery (2011) (0)
- Cardiovascular complications in CKD 5D (1) (2011) (0)
- Detailed analysis of cholesterol metabolism predicts cardiovascular events in patients admitted for coronary angiography. (2017) (0)
- MO556TREATMENT OF ANAEMIA WITH ERYTHROPOIESIS STIMULATION AGENTS (ESAS) AND CONCOMITANT THERAPIES AMONG PATIENTS WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) IN GERMANY, SPAIN AND THE UK: A RETROSPECTIVE CHART REVIEW (2021) (0)
- Markers of cholesterol metabolism and cardiovascular outcomes in patients with chronic kidney disease (2020) (0)
- ANTI-INFLAMMATORY EFFECTS OF ANGIOTENSIN II SUBTYPE 1-RECEPTOR BLOCKADE IN HYPERTENSIVE PATIENTS WITH MICRO-INFLAMMATION: 8A.4 (2004) (0)
- Therapeutic apheresis within immune-mediated neurological disorders: dosing and its effectiveness (2020) (0)
- Transplantation / Clinical studies (2011) (0)
- Circulating Long Noncoding RNA TrAnscript Predicting Survival in AKI Is a Predictor of Mortality in Critically Ill Patients with Acute Kidney Injury (2014) (0)
- A Common Variant In The Nlrp3 Inflammasome Locus Associates With Mortality (2019) (0)
- Olmesartan Medoxomil (2012) (0)
- Dialysis / Cardiovascular complications (2011) (0)
- SP359PROGNOSTIC VALUE OF THE ,,ESTIMATED ALBUMIN EXCRETION RATE” TO PREDICT RENAL EVENTS IN CHRONIC KIDNEY DISEASE (2015) (0)
- l-Homoarginine and its AGXT2-metabolite GOCA in chronic kidney disease as markers for clinical status and prognosis (2018) (0)
- Abstract 17393: Markers of Cholesterol Metabolism Predict Cardiovascular Events (2017) (0)
- Abstract 11343: High Density Lipoprotein (HDL) From Patients with Early Kidney Disease (CKD) Exerts Adverse Endothelial Effects (2011) (0)
- Kidney outcome after mild to moderate COVID-19. (2023) (0)
- LIPIDS AND OTHER RISK FACTORS TO012 DYSFUNCTIONAL HIGH-DENSITY LIPOPROTEIN (HDL) IN CHRONIC KIDNEY DISEASE (CKD): A PROSPECTIVE OBSERVATIONALTRIALOF 3.306 PATIENTS TO014 HYPERTENSIVE URGENCIES WITH HYPOVOLEMIA IN CKD PATIENTS (2013) (0)
- P1544No associations of plasma oxyphytosterol levels and cardiovascular events in patients admitted for coronary angiography (2018) (0)
- ENDOTHELIAL FUNCTION, INSULIN RESISTANCE, ADIPONECTIN LEVEL IN HYPERTENSIVE FEMALES WITH RHEUMATOID ARTHRITIS AND RENAL DYSFUNCTION (2018) (0)
- FGFR4 and Klotho Polymorphisms Are Not Associated with Cardiovascular Outcomes in Chronic Kidney Disease (2021) (0)
- [Regional anticoagulation with citrate]. (2013) (0)
- When should atheromatous renal artery stenosis be considered? A guide for the general physician (2003) (0)
- [Dyslipoproteinemia: its importance in nephrology]. (1993) (0)
- The effect of sKlotho on left ventricular Mass and echocardiographic Changes in Patients with chronic Kidney Disease (2016) (0)
- [Acute renal failure]. (2011) (0)
- MP251S-ADENOSYLHOMOCYSTEINE: A NOVEL NON-TRADITIONAL CARDIOVASCULAR RISK FACTOR IN CKD (2016) (0)
- MP544ONLINE HEMODIAFILTRATION ELIMINATES S ADENOSYLHOMOCYSTEINE MORE EFFICIENTLY THAN STANDARD HEMODIALYSIS (2016) (0)
- Combined Effects of Lung Function, Blood Gases and Renal Function on Exacerbations in Stable COPD: Data from the Cosyconet Cohort (2019) (0)
- Prescription of Direct Oral Anticoagulants to Patients With Moderate-to-Advanced CKD: Too Little or Just Right? (2021) (0)
- Sixty Years of ‘Extended Dialysis’ in the ICU (2006) (0)
- Anemia and Progression of Chronic Kidney Disease (2011) (0)
- Oxidant Stress Impairs In Vivo Reendothelialization Capacity of Endothelial Progenitor Cells From Patients With Type 2 Diabetes Mellitus Restoration by the Peroxisome Proliferator-Activated Receptor- (cid:1) Agonist Rosiglitazone Molecular Cardiology (2007) (0)
- FO014IMPACT OF INDIVIDUAL I.V. IRON PREPARATIONS ON DIFFERENTIATION OF MACROPHAGES AND DENDRITIC CELLS (2015) (0)
- Bone and mineral diseases - 1 (2012) (0)
- OP-NDTP180065 437..442 (2018) (0)
- Endothelial Biomedicine: Uremia (2007) (0)
- From WEDA to EDTA to ERA: 60 years of supporting European Nephrology and counting. (2022) (0)
- Response to Letter by Tsuda (2009) (0)
- Improvement of Plasma Amino Acids During Fractionated Plasma Separation and Adsorption (Prometheus (2006) (0)
- Heart and kidney disease: a cardiovascular high-risk constellation (2020) (0)
- [Symptom control in heart failure patients - how to handle GFR decrease and hyperkalaemia]. (2021) (0)
- MO592INTERLEUKIN-1A (IL-1A) IS A CENTRAL REGULATOR OF INFLAMMATION IN CARDIOVASCULAR AND KIDNEY DISEASES (2021) (0)
- SP358PULMONARY HYPERTENSION PREDICTS ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-ADVANCED CKD (2015) (0)
- FP302INTERMEDIATE MONOCYTES ARE PREDICTORS OF CARDIOVASCULAR BUT NOT OF RENAL EVENTS (2015) (0)
- FP251THE PROGNOSTIC VALUE OF "ESTIMATED ALBUMIN EXCRETION RATE" (EAER) VERSUS URINE ALBUMIN/CREATININE RATIO (ACR) FOR PREDICTING ADVERSE CARDIOVASCULAR OUTCOME AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE G2-G4 (2015) (0)
- CLINICAL ACUTE KIDNEY INJURY 1 (2014) (0)
- MP177LIPOPROTEIN(A) AND THE RISK OF MORTALITY IN PATIENTS WITH ESTABLISHED CORONARY HEART DISEASE: A PROSPECTIVE STUDY OF 116,548 PATIENTS (2017) (0)
- General & clinical epidemiology CKD 1-5 (1) (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Danilo Fliser?
Danilo Fliser is affiliated with the following schools:
